ARTELINIC ACID

• CAT Number: M028238
• CAS Number: 120020-26-0
• Molecular Formula: C23H30O7
• Molecular Weight: 418.48
• Purity: ≥95%
• Storage: -20°C
• IUPAC Name: 4-[[(1R,4S,5R,8S,9R,10S,12R,13R)-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecan-10-yl]oxymethyl]benzoic acid
• InChI: InChI=1S/C23H30O7/c1-13-4-9-18-14(2)20(26-12-15-5-7-16(8-6-15)19(24)25)27-21-23(18)17(13)10-11-22(3,28-21)29-30-23/h5-8,13-14,17-18,20-21H,4,9-12H2,1-3H3,(H,24,25)/t13-,14-,17+,18+,20+,21-,22-,23-/m1/s1
• InChIKey: UVNHKOOJXSALHN-ILQPJIFQSA-N
• SMILES: CC1CCC2C(C(OC3C24C1CCC(O3)(OO4)C)OCC5=CC=C(C=C5)C(=O)O)C

Artelinic acid（Cat No.:M028238）, a derivative of artemisinin, is a valuable compound used in antimalarial research, particularly in combating multidrug resistance of Plasmodium falciparum, the malaria-causing parasite. Its flexibility allows for administration through various routes, such as intravenous, intramuscular, and oral, making it suitable for different treatment protocols. The compound’s association with artemisinin, a potent antimalarial drug, adds to its significance in malaria research, providing a potential solution to the challenge of drug-resistant strains of the parasite. Artelinic acid holds promise in advancing malaria treatment strategies and addressing the global burden of this infectious disease.